{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-15",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "San Diego",
      "state": "CA",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "72651",
      "recalling_firm": "Ameditech Inc",
      "address_1": "9940 Mesa Rim Rd",
      "address_2": "N/A",
      "postal_code": "92121-2910",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide Distribution.",
      "recall_number": "Z-0504-2016",
      "product_description": "iCup DX 12 Panel w/ Adulterant, Item No. I-DXA-1127-023",
      "product_quantity": "9,566 kits",
      "reason_for_recall": "Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.",
      "recall_initiation_date": "20151116",
      "center_classification_date": "20151224",
      "termination_date": "20161109",
      "report_date": "20151230",
      "code_info": "143345  143442  151537  152163  152334  152674  152697  153075  153127  153216  153390  153499  153634"
    }
  ]
}